Erasca (ERAS) director receives grant of 29,888 stock options at $16.01
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Erasca, Inc. director Valerie Denise Harding received a stock option grant covering 29,888 shares of Common Stock. The options have an exercise price of $16.01 per share and expire on June 26, 2036.
All 29,888 options vest on June 26, 2027, provided she remains in continuous service with the company through that date. Following this grant, she holds 29,888 derivative securities directly, reflecting a routine, compensation-related award rather than an open-market purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Start Valerie Denise Harding
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock option (right to buy) | 29,888 | $0.00 | -- |
Holdings After Transaction:
Stock option (right to buy) — 29,888 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 29,888 options
Underlying shares: 29,888 shares
Exercise price: $16.01 per share
+3 more
6 metrics
Option grant size
29,888 options
Stock option grant reported June 26, 2026
Underlying shares
29,888 shares
Common Stock underlying granted options
Exercise price
$16.01 per share
Conversion or exercise price of options
Vesting date
June 26, 2027
100% of options vest on this date
Expiration date
June 26, 2036
Option expiration
Post-grant derivative holdings
29,888 options
Total derivative securities following transaction
Key Terms
Stock option (right to buy), Grant, award, or other acquisition, Common Stock, continuous service
4 terms
Stock option (right to buy) financial
"security_title: "Stock option (right to buy)""
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
continuous service financial
"subject to the Reporting Person's continuous service to the Issuer"
FAQ
What did Erasca (ERAS) director Valerie Denise Harding report in this Form 4?
She reported receiving a stock option grant for 29,888 shares of Erasca Common Stock. The options are a compensation-related award, not an open-market trade, and give her the right to buy shares at a fixed exercise price in the future.
What is the exercise price of Valerie Denise Harding’s Erasca (ERAS) stock options?
The options have an exercise price of $16.01 per share. This means she can buy Erasca Common Stock at $16.01 per share once the options vest, regardless of the market price at that time.
When do Valerie Denise Harding’s Erasca (ERAS) stock options vest and expire?
All 29,888 options vest on June 26, 2027, if she remains in continuous service to Erasca through that date. The options then remain exercisable until their expiration on June 26, 2036, subject to plan and agreement terms.
Is Valerie Denise Harding’s Form 4 for Erasca (ERAS) a buy or a sale of stock?
The Form 4 reports an acquisition through a grant of stock options, not a market buy or sale. The transaction code "A" reflects a grant or award, so no shares were bought or sold in the open market.
How many Erasca (ERAS) derivative securities does Valerie Denise Harding hold after this grant?
After the transaction, she holds 29,888 derivative securities directly, all from this stock option grant. These options each relate to one share of Erasca Common Stock, giving her potential future ownership if she exercises them.